WHO Executive Board Wraps Up Post-WHA Work 27/05/2014 by Intellectual Property Watch Leave a Comment At the World Health Organization 135th Executive Board meeting this week, member states discussed improvements to cut down on lengthy World Health Assemblies, and adopted two reports for further discussion on surgical care and anaesthesia, and the health impact of air pollution.
NCDs As Global Policy Concern: WHO Approves Plan To Tackle Scourge 26/05/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The prevention and control of non-communicable diseases (NCDs) stands high on the agenda of World Health Organization member countries, many of them said last week. Governments called for a multi-stakeholder approach to tackle the problem, governed by firm rules, and some asked for ways to regulate products that increase risk factors.
WHO To Develop Global Action Plan Against Antibiotic Resistance 26/05/2014 by Catherine Saez, Intellectual Property Watch 1 Comment Faced with growing global concern over microbial resistance to antibiotic treatments, the World Health Assembly last week adopted a resolution to establish a global action plan on antimicrobial resistance.
WHO Takes Step Toward Policy Of Engagement With Lobbyists, Foundations 25/05/2014 by William New, Intellectual Property Watch Leave a Comment The World Health Organization today (24 May) adopted a one-year plan to come up with a policy on engagement with “non-state actors” – industry, nongovernmental groups, foundations and academics.
World Health Assembly Approves Plan To Strengthen Access To Essential Medicines 24/05/2014 by Joséphine De Ruyck for Intellectual Property Watch, Julia Fraser for Intellectual Property Watch and William New 2 Comments World Health Organization members tonight approved a resolution aimed at improving access to essential medicines. Agreement came after a compromise on a proposed provision referencing other medicines that are not qualified as essential medicines.
WHO Agrees Plan For Sustainable R&D For Developing Countries; TDR May Host Pooled Fund 24/05/2014 by William New, Intellectual Property Watch 1 Comment World Health Organization members in committee today agreed on a plan taking forward efforts to find alternative financing for diseases predominantly afflicting poor populations. The draft decision was modified overnight to address concerns that the agreed path assess projects on their success in finding alternatives, allow coverage of all types of disease, and not exclude […]
WHO Members Note Reform Progress, Ask For Speedy Implementation 23/05/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment World Health Organization members this week examined progress made in the ongoing reform of the UN agency. Members speaking in committee made firm requests for speedy implementation of reforms, and commended WHO’s efforts toward financial sustainability, with some cautions.
WHO Wrestles With Plan To Pursue R&D For Neglected Diseases 23/05/2014 by William New, Intellectual Property Watch 1 Comment World Health Organization members today are expected to address a proposal on future efforts to find a solution to the longstanding problem of sustainable funding for research into diseases predominantly afflicting poor populations. An effort to close the topic yesterday was delayed when a proposal was put forward that named a WHO department as the potential host of the future activities on this issue.
WHA: New Draft Decision On Non-State Actors Sets Plan For Next Year 23/05/2014 by William New, Intellectual Property Watch 1 Comment A new draft decision putting action on a proposal for external actors’ engagement with the World Health Organization on track for next year will be considered by a committee at the World Health Assembly.
WHA: Experts Discuss Innovation, Access For Middle Income Countries 23/05/2014 by Joséphine De Ruyck for Intellectual Property Watch and Julia Fraser for Intellectual Property Watch Leave a Comment Country officials, academics and leading global health advocates this week raised one of the key concerns of this year’s World Health Assembly: innovation and access to medicines in middle-income countries. Government procurement strategies, voluntary and compulsory licensing, de-linkage models and UNITAID mechanisms were among some of the solutions put forward.